• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

危重症流感病毒感染患者的转归。

Outcome of critically ill patients with influenza virus infection.

机构信息

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN 55905, United States.

出版信息

J Clin Virol. 2009 Nov;46(3):275-8. doi: 10.1016/j.jcv.2009.07.015. Epub 2009 Aug 20.

DOI:10.1016/j.jcv.2009.07.015
PMID:19699141
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7108217/
Abstract

BACKGROUND

Influenza is a major cause of morbidity and mortality, with its greatest burden on the elderly and patients with chronic co-morbidities in the intensive care unit (ICU). An accurate prognosis is essential for decision-making during pandemic as well as interpandemic periods.

METHODS

A retrospective cohort study was conducted to determine prognostic factors influencing short term outcome of critically ill patients with confirmed influenza virus infection. Baseline characteristics, laboratory and diagnostic findings, ICU interventions and complications were abstracted from medical records using standard definitions and compared between hospital survivors and non-survivors with univariate and multivariate logistic regression analyses.

RESULTS

111 patients met the inclusion criteria. Acute respiratory distress syndrome (ARDS) complicated ICU course in 25 (23%) of the patients, with mortality rate of 52%. Multivariate logistic regression analysis identified the following predictors of hospital mortality: Acute Physiology and Chronic Health Evaluation (APACHE) III predicted mortality (Odds ratio [OR] 1.49, 95% confidence interval [CI] 1.1-2.1 for 10% increase), ARDS (OR 7.7, 95% CI 2.3-29) and history of immunosuppression (OR 7.19, 95% CI 1.9-28).

CONCLUSIONS

APACHE III predicted mortality, the development of ARDS and the history of immunosuppression are independent risk factors for hospital mortality in critically ill patients with confirmed influenza virus infection.

摘要

背景

流感是发病率和死亡率的主要原因,其对重症监护病房(ICU)中老年人和患有慢性合并症的患者的负担最大。准确的预后对于大流行期间和大流行间期的决策至关重要。

方法

本回顾性队列研究旨在确定影响确诊流感病毒感染的危重症患者短期预后的预后因素。使用标准定义从病历中提取基线特征、实验室和诊断结果、ICU 干预措施和并发症,并通过单变量和多变量逻辑回归分析比较医院幸存者和非幸存者之间的差异。

结果

符合纳入标准的患者有 111 例。急性呼吸窘迫综合征(ARDS)使 25 例(23%)患者的 ICU 病程复杂化,死亡率为 52%。多变量逻辑回归分析确定了医院死亡率的以下预测因素:急性生理学和慢性健康评估(APACHE)III 预测死亡率(优势比 [OR] 1.49,95%置信区间 [CI] 1.1-2.1,每增加 10%)、ARDS(OR 7.7,95% CI 2.3-29)和免疫抑制史(OR 7.19,95% CI 1.9-28)。

结论

APACHE III 预测死亡率、ARDS 的发生和免疫抑制史是确诊流感病毒感染的危重症患者医院死亡率的独立危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0f/7108217/99b7d3a2c982/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0f/7108217/99b7d3a2c982/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0f/7108217/99b7d3a2c982/gr1_lrg.jpg

相似文献

1
Outcome of critically ill patients with influenza virus infection.危重症流感病毒感染患者的转归。
J Clin Virol. 2009 Nov;46(3):275-8. doi: 10.1016/j.jcv.2009.07.015. Epub 2009 Aug 20.
2
[Clinical characteristics and prognostic factors of adult patients with acute respiratory failure due to influenza infection].[流感感染所致成人急性呼吸衰竭患者的临床特征及预后因素]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Nov;32(11):1304-1309. doi: 10.3760/cma.j.cn121430-20200827-00598.
3
Risk factor analysis of nosocomial lower respiratory tract infection in influenza-related acute respiratory distress syndrome.流感相关性急性呼吸窘迫综合征患者下呼吸道医院感染的危险因素分析。
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620942417. doi: 10.1177/1753466620942417.
4
Clinical findings and demographic factors associated with ICU admission in Utah due to novel 2009 influenza A(H1N1) infection.因新型 2009 流感 A(H1N1)感染而入住犹他州 ICU 的临床发现和人口统计学因素。
Chest. 2010 Apr;137(4):752-8. doi: 10.1378/chest.09-2517. Epub 2009 Nov 20.
5
Critically Ill patients with 2009 influenza A(H1N1) in Mexico.墨西哥2009年甲型H1N1流感危重症患者。
JAMA. 2009 Nov 4;302(17):1880-7. doi: 10.1001/jama.2009.1536. Epub 2009 Oct 12.
6
Clinical Characteristics and Predictors of Mortality in Critically Ill Adult Patients with Influenza Infection.重症成人流感感染患者的临床特征和死亡预测因素。
Int J Environ Res Public Health. 2021 Apr 1;18(7):3682. doi: 10.3390/ijerph18073682.
7
Influenza-induced acute respiratory distress syndrome during the 2010-2016 seasons: bacterial co-infections and outcomes by virus type and subtype.2010-2016 年季节流感诱发的急性呼吸窘迫综合征:病毒类型和亚型的细菌合并感染和结局。
Clin Microbiol Infect. 2020 Jul;26(7):947.e1-947.e4. doi: 10.1016/j.cmi.2020.03.010. Epub 2020 Mar 20.
8
Heparin-binding protein (HBP) in critically ill patients with influenza A(H1N1) infection.重症甲型 H1N1 流感患者中肝素结合蛋白 (HBP) 的变化。
Clin Microbiol Infect. 2013 Dec;19(12):1122-8. doi: 10.1111/1469-0691.12156. Epub 2013 Feb 12.
9
Outcomes of Herpes Simplex Virus Pneumonitis in Critically Ill Patients.危重症患者单纯疱疹病毒肺炎的结局。
Viruses. 2022 Jan 21;14(2):205. doi: 10.3390/v14020205.
10
[Risk factors of the occurence and death of acute respiratory distress syndrome: a prospective multicenter cohort study].[急性呼吸窘迫综合征发生与死亡的危险因素:一项前瞻性多中心队列研究]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014 Nov;26(11):773-9. doi: 10.3760/cma.j.issn.2095-4352.2014.11.002.

引用本文的文献

1
Comparison of COVID-19 with influenza A in the ICU: a territory-wide, retrospective, propensity matched cohort on mortality and length of stay.比较 ICU 中 COVID-19 与甲型流感:一项全岛范围、回顾性、倾向评分匹配队列研究,评估死亡率和住院时间。
BMJ Open. 2023 Jul 10;13(7):e067101. doi: 10.1136/bmjopen-2022-067101.
2
Optimization of an Inclusion Body-Based Production of the Influenza Virus Neuraminidase in .基于包涵体的流感病毒神经氨酸酶生产的优化。
Biomolecules. 2022 Feb 19;12(2):331. doi: 10.3390/biom12020331.
3
Risk Factors Associated with 30-Day Mortality in Older Patients with Influenza.

本文引用的文献

1
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008.流感的预防与控制:免疫实践咨询委员会(ACIP)2008年建议
MMWR Recomm Rep. 2008 Aug 8;57(RR-7):1-60.
2
[Lessons from SARS: a new potential therapy for acute respiratory distress syndrome (ARDS) with angiotensin converting enzyme 2 (ACE2)].[严重急性呼吸综合征的经验教训:血管紧张素转换酶2(ACE2)对急性呼吸窘迫综合征(ARDS)的一种新的潜在治疗方法]
Masui. 2008 Mar;57(3):302-10.
3
Age-related trends in the timeliness and prediction of medical visits, hospitalizations and deaths due to pneumonia and influenza, British Columbia, Canada, 1998-2004.
老年流感患者30天死亡率的相关危险因素
J Clin Med. 2021 Aug 11;10(16):3521. doi: 10.3390/jcm10163521.
4
Clinical Characteristics and Predictors of Mortality in Critically Ill Influenza Adult Patients.重症成年流感患者的临床特征及死亡预测因素
J Clin Med. 2020 Apr 9;9(4):1073. doi: 10.3390/jcm9041073.
5
Risk Factors for Influenza-Associated Severe Acute Respiratory Illness Hospitalization in South Africa, 2012-2015.2012 - 2015年南非流感相关严重急性呼吸疾病住院治疗的风险因素
Open Forum Infect Dis. 2017 Feb 10;4(1):ofw262. doi: 10.1093/ofid/ofw262. eCollection 2017 Winter.
6
Molecular point-of-care testing for respiratory viruses versus routine clinical care in adults with acute respiratory illness presenting to secondary care: a pragmatic randomised controlled trial protocol (ResPOC).针对到二级医疗机构就诊的急性呼吸道疾病成人患者,呼吸道病毒分子即时检测与常规临床护理的比较:一项实用随机对照试验方案(ResPOC)
BMC Infect Dis. 2017 Feb 6;17(1):128. doi: 10.1186/s12879-017-2219-x.
7
Lethal H1N1 influenza A virus infection alters the murine alveolar type II cell surfactant lipidome.致死性甲型H1N1流感病毒感染会改变小鼠肺泡II型细胞表面活性物质脂质组。
Am J Physiol Lung Cell Mol Physiol. 2016 Dec 1;311(6):L1160-L1169. doi: 10.1152/ajplung.00339.2016. Epub 2016 Nov 11.
8
Point-of-care testing for respiratory viruses in adults: The current landscape and future potential.成人呼吸道病毒的即时检测:现状与未来潜力
J Infect. 2015 Nov;71(5):501-10. doi: 10.1016/j.jinf.2015.07.008. Epub 2015 Jul 26.
9
TGF-β-induced IL-6 prevents development of acute lung injury in influenza A virus-infected F508del CFTR-heterozygous mice.转化生长因子-β诱导的白细胞介素-6可预防甲型流感病毒感染的F508del囊性纤维化跨膜传导调节因子杂合小鼠急性肺损伤的发生。
Am J Physiol Lung Cell Mol Physiol. 2015 Jun 1;308(11):L1136-44. doi: 10.1152/ajplung.00078.2015. Epub 2015 Apr 3.
10
Pathogenic influenza B virus in the ferret model establishes lower respiratory tract infection.雪貂模型中的致病性乙型流感病毒可建立下呼吸道感染。
J Gen Virol. 2014 Oct;95(Pt 10):2127-2139. doi: 10.1099/vir.0.064352-0. Epub 2014 Jul 2.
1998 - 2004年加拿大不列颠哥伦比亚省肺炎和流感导致的医疗就诊、住院及死亡的及时性和预测方面的年龄相关趋势
Vaccine. 2008 Mar 4;26(10):1397-403. doi: 10.1016/j.vaccine.2007.11.090. Epub 2007 Dec 26.
4
Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada.加拿大安大略省流感住院患者的抗病毒治疗及治疗结果
Clin Infect Dis. 2007 Dec 15;45(12):1568-75. doi: 10.1086/523584.
5
Effectiveness of influenza vaccine in the community-dwelling elderly.流感疫苗对社区老年人的有效性。
N Engl J Med. 2007 Oct 4;357(14):1373-81. doi: 10.1056/NEJMoa070844.
6
Mortality benefits of influenza vaccination in elderly people: an ongoing controversy.老年人流感疫苗接种的死亡率益处:仍在持续的争议。
Lancet Infect Dis. 2007 Oct;7(10):658-66. doi: 10.1016/S1473-3099(07)70236-0.
7
Virally delivered cytokines alter the immune response to future lung infections.病毒递送的细胞因子会改变对未来肺部感染的免疫反应。
J Virol. 2007 Dec;81(23):13105-11. doi: 10.1128/JVI.01544-07. Epub 2007 Sep 12.
8
Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection.抑制细胞因子反应并不能预防致命的H5N1流感感染。
Proc Natl Acad Sci U S A. 2007 Jul 24;104(30):12479-81. doi: 10.1073/pnas.0705289104. Epub 2007 Jul 17.
9
Avian influenza virus (H5N1): a threat to human health.甲型流感病毒(H5N1):对人类健康的威胁。
Clin Microbiol Rev. 2007 Apr;20(2):243-67. doi: 10.1128/CMR.00037-06.
10
Induction of pro- and anti-inflammatory molecules in a mouse model of pneumococcal pneumonia after influenza.流感后肺炎球菌肺炎小鼠模型中促炎和抗炎分子的诱导
Comp Med. 2007 Feb;57(1):82-9.